Nitigna Vikas Desai MD
Addiction
Assistant Professor, Psychiatry, Boston Univ Sch of Med
Join to View Full Profile
200 Springs RdBedford, MA 01730
Phone+1 781-687-3006
Fax+1 781-687-3006
Dr. Desai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 1988 - 1991
Waltham Weston Hospital Medical CenterInternship, Internal Medicine, 1987 - 1988
Government Medical College GujuratClass of 1984
Certifications & Licensure
MA State Medical License 1989 - 2025
FL State Medical License 1994 - 2024
GA State Medical License 1995 - 1995
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
Publications & Presentations
PubMed
- 2 citationsBuprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review.Steven D. Shirk, Victoria Ameral, Shane W. Kraus, Joseph R. Houchins, Megan M. Kelly
Journal of Dual Diagnosis. 2021-06-27 - 16 citationsLong-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health AdministrationMegan M. Kelly, Erin D. Reilly, Timothy Quiñones, Nitigna Desai, Robert A. Rosenheck
Drug and Alcohol Dependence. 2018-02-01 - 1 citationsFactors to Consider for Reducing US Opioid-Related Deaths: Looking Beyond Access.Nitigna Desai, Shane W. Kraus, Joseph R. Houchins
JAMA Psychiatry. 2017-11-01
Authored Content
- Long-Acting Intramuscular Naltrexone for Opioid Use Disorder: Utilization and Association with Multi-Morbidity Nationally in the Veterans Health AdministrationNovember 2017
Press Mentions
Webinar Will Provide Overview of Stimulant Use Disorder and Polysubstance UseJuly 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
